Schedule 13G ownership disclosure

Atea Pharmaceuticals Inc

Common Stock, par value $0.001 · CUSIP: 04683R106

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JPM Partners LLC

    Shares: 5,866,025 · Class: 6.9%

  • Jean-Pierre Sommadossi

    Shares: 8,876,453 · Class: 10.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-071707
Form type
SCHEDULE 13G/A
Filer
Atea Pharmaceuticals, Inc.
CIK
CIK 1593899
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub